Focal proliferative changes in the acinar cells of the pancreas of rats have been induced by several systemically administered carcinogens including azaserine, N-nitrosobis(2-oxopropyl)amine, N-nitroso-(2-hydroxypropyl) (2-oxopropyl)amine, and Nb-(N-methyl-N-nitrosocarbamoyl)-L-ornithine (MNCO). Foci, nodules, and adenomas induced by these carcinogens are usually made up of atypical-appearing acinar cells that maintain a high degree of differentiation, but a minority of these lesions exhibit anaplastic cellular changes that suggest the development of malignant potential. Such anaplasia may occupy the whole of smaller lesions or may occur as a secondary focal change within larger nodules or adenomas. Many foci and nodules per pancreas have been induced by single or multiple exposures to these known genotoxic carcinogens, but relatively few of them develop into carcinomas. Azaserine and MNCO have induced acinar cell carcinomas in rats. Those induced by azaserine have exhibited a broad spectrum of histologic variants, including ductlike, cystic, and undifferentiated patterns. Higher doses of MNCO have induced a second pattern of change in the pancreatic lobules of rats, which includes cystic and tubular ductlike structures that have been called cystic and tubular ductal complexes.
Introduction
Several chemicals have been demonstrated experimentally to induce carcinomas in the rodent pancreas (1) . Lesions induced by azaserine, N-nitrosobis(2-oxopropyl)amine (BOP), N-nitroso(2-hydroxypropyl)-(2-oxopropyl)amine (HPOP), and Nb-(N-methyl-N-nitrosocarbamoyl)-L-ornithine (MNCO) in the rat pancreas will be listed and compared. MNCO has also induced carcinomas in the pancreas of hamsters (2) , and the effect of this carcinogen will be compared in the two species. All of the carcinogens to be discussed are mutagens and have been demonstrated to induce DNA damage in the pancreas by alkaline elution analysis of DNA. Thus all of these carcinogens are genotoxic agents and are classed as initiators.
Azaserine-Induced Lesions
The major experience in our laboratory has been with azaserine which, although it acts without S-9 as a *Department of Pathology, Dartmouth Medical School, Hanover, NH 03756. bacterial mutagen in the Ames system, appears to be activated in mammalian cells by a pyridoxal-dependent enzyme system (3) . N-7-Carboxymethylguanine was identified in DNA from cells exposed to azaserine (4) , a finding consistent with the generation of diazoacetate as the ultimate reactive carcinogenic species derived from azaserine by an a,,P-elimination reaction.
Foci of phenotypically altered acinar cells have been identified in the pancreas as early as 1 month after a single injection of azaserine. These foci are about the size of small islets. Some of them have a high mitotic index in routine histologic sections, and an even higher labeling index in autoradiograms done to detect S-phase DNA synthesis (5) . As expected from this observation, some of the foci grow at variable rates and form grossly visible nodules within 4 to 6 months after azaserine injection. In the vast majority of these lesions the acinar cells retain a high degree of differentiation. Phenotypic changes include reduced zymogen content, increased cytoplasmic basophilia, and altered nuclear size and configuration.
Some atypical acinar cell nodules (AACN) reach diameters of 2 to 3 mm; still fewer, the 3 Azaserine-induced carcinomas exhibit a spectrum of histologic patterns (6) . Most show evidence of acinar cell differentiation. Table 1 been higher in male rats than in female rats by a ratio of approximately 2:1. This difference in sensitivity to azaserine between the two sexes is also evident in nodule-induction studies in which we have demonstrated that 1.4 to 4 times as many nodules appear in male rats as in female rats after equivalent regimens of azaserine treatment (7) . The basis for this sex difference in sensitivity to azaserine is not known. These studies have been done mainly in Wistar and Lewis strain rats. We have shown that Fischer 344 rats of either sex develop fewer acinar cell lesions in response to azaserine (7) . Diet has been shown to influence the rate of progression of azaserine-induced lesions. Purified diets high (20%) in unsaturated fats have been shown to enhance the rate of progression of azaserine-induced lesions in comparison to diets that contain the standard (5%) level of corn oil or a high level of saturated fat (18% coconut oil plus 2% corn oil). In the azaserine model, pancreatic neoplasms have increased in incidence and number both when the diet was fed continuously during a prolonged period of exposure to azaserine (8) , and when, in one experiment, exposure to azaserine was completed before the test diets were fed (9) . The number of tumors per pancreas has been three to four times as great in the animals fed diets high in unsaturated fats as in their controls.
Lesions Induced by Derivatives of Dipropyinitrosamine
The induction of pancreatic carcinomas in hamsters by BOP and HPOP has been well characterized (10) . In hamsters, the vast majority of carcinomas have been classed as ductal in histologic type, although we have also observed a low incidence of carcinomas with mixtures of malignant ductlike and acinar cells in BOP-treated hamsters. Several investigators have reported failing to induce pancreatic neoplasms in rats treated with BOP or related nitrosamines (11) . In biochemical studies of the effect of BOP and HPOP in Lewis rats, we observed evidence of damage by means of an alkaline elution analysis of pancreatic DNA from treated rats (11) . The amount of damage induced by 100 mg/kg of BOP or 40 mg/kg of HPOP appeared to be less than that induced by carcinogenic doses of azaserine, i.e., 10 to 30 mg/kg, but the complete lack of pancreatic carcinogenesis in BOP-treated rats was puzzling. Since we had previously shown that young rats were more sensitive to AACN induction by azaserine than were older or adult rats (12), we treated a group of 2 to 3 week-old rats with a single injection of BOP or HPOP All these rats developed multiple AACN in their pancreases within 4 months after carcinogen injection ( Fig. 1) (13) , and has damaged pancreatic DNA in rats (14) . It is an effective carcinogen in long-term studies although the incidence of carcinomas was higher in the kidney, skin, and breast than in the pancreas in a one-year study (15) . This discussion will focus on the lesions induced in the pancreas by MNCO in Wistar rats. Low doses of MNCO induce AACN, whereas in rats given higher doses there is progressive replacement of the lobular tissue of the pancreas by cystic lesions that we have referred to as cystic ductal complexes. Some of the AACN progress to become acinar cell adenomas, and acinar cell adenocarcinomas.
The cystic lesions in the pancreas consist of multilocular structures with thin fibrous walls lined by a single layer of flattened or cuboidal epithelium (Fig. 2) interspersed with acini. The ratio of the diameter of the lumen to the height of the epithelium is in the range of 1:1. These lesions occur less frequently than either AACN or cystic ductal complexes. The pancreas of MNCO-treated rats contains a larger spectrum of lesions than are usually seen after azaserine treatment, but we have seen a low incidence and small number of both cystic and tubular ductal complexes in azaserine-treated rats. The lesions that appear to have the greatest potential for progression to neoplasia appear to be the AACN which are presumed to be the precursors to acinar cell adenomas and carcinomas. More than 100 such foci have been counted in a pancreas from a rat given multiple doses of MNCO. It is apparent that this genotoxic initiator, like azaserine, BOP, and HPOP, can induce many potentially preneoplastic foci in the rat pancreas.
MNCO-Induced Lesions in Hamster Pancreas
We have recently reported the induction of ductlike carcinomas in the pancreas of Syrian golden hamsters that were treated with MNCO (2). We had earlier reported the effect of smaller doses of MNCO in a 6-month study (16) . The histologic appearance of these carcinomas was similar to those that have been induced by BOP and related compounds. MNCO induced a spectrum of lesions in the hamster pancreas similar to that already described in the rat. Several foci of atypical acinar cells were observed (Fig. 3) . The incidence was related to the total dose of MNCO, but it was always less than 100%, and there were usually only one or two such lesions per pancreas. We also observed a doserelated incidence of cystic ductal complexes and occasional tubular ductal complexes that replaced lobular acinar tissue (Fig. 4) . The latter structures are similar to the BHP-induced lesions in the hamster that Flaks has called "pseudoductular transformation" (17) . Some lesions had characteristics of both cystic ductal complexes and tubular ductal complexes while occasional AACN had tubular units similar to those seen in tubular ductal complexes. Thus, while most lesions could easily be categorized as AACN, tubular ductal complexes, or cystic ductal complexes, there were some borderline lesions that were difficult to classify. This suggests the possibility that tubular ductal complexes and cystic ductal complexes might have been derived from carcinogen-altered acinar cells. We also saw a dose-related Figure 5 . Experience with several carcinogens supports the view that the carcinogen-induced lesions are derived primarily, or exclusively, from acinar cells in the rat pancreas (5) . HPOP and MNCO are carcinogens that induce acinar cell carcinomas in the rat and ductlike carcinomas in the hamster. Thus, the response of these two species to specific chemical carcinogens differs in a consistent fashion. Pathways have been proposed in both the rat and the hamster whereby ductlike carcinomas might arise from carcinogen-altered acinar tissue. The possibility that the carcinomas induced by these two carcinogens arise from acinar cells in both rats and hamsters should be considered, although the data we have presented is no more than suggestive of this pathway. We also consider the alternate possibility that the carcinomas arise from different cells of the pancreas in the two species, i.e., acinar cells in the rat and ductal cells in the hamster. The pathways outlined in Figure 5 do not reflect the view of Pour that ductal complexes arise by proliferation of ductular and/or centroacinar cells (20) . The relative importance of lesions derived from the two cell types in regard to the origin of carcinomas in the hamster is unknown. We believe that a similar situation pertains in regard to pancreatic carcinogenesis in the human, i.e., that the relative proportion of tumors arising as a result of transformation of acinar cells and ductal cells is not known with certainty.
Experience with the number and types of lesions that have been induced in the rat pancreas by genotoxic carcinogens such as azaserine, BOP, HPOP, and MNCO provides a basis for comparison and evaluation of the carinogenic potential of additional chemical agents. Proliferative lesions of acinar cells have been the most frequent manifestation of systemic exposure to pancreatic carcinogens in the rat.
